22 May 2013
Keywords: biosante, bio-e-gel, completes, phase, iii, pharmaceuticals, usa
Article | 18 April 2005
BioSante Pharmaceuticals of the USA has completed its Phase III safety and efficacy trial of Bio-E-Gel (bioidentical estradiol transdermal gel)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 April 2005
11 April 2005
21 May 2013
© 2013 thepharmaletter.com